Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 3/20 | 0.49 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.46 |
| ▸ | RXRA | P19793 | 8/20 | 0.45 |
| ▸ | RXRB | P28702 | 7/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.45 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.45 |
| ▸ | RXRG | P48443 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27613996 | 0.84 | NR4A2 (0.59) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL1750568 | 0.83 | PLA2G4B (0.63) | ALDH1A1PLA2G4BRXRARXRBNPC1 | |
| SCHEMBL2467522 | 0.83 | ALDH1A1 (0.54) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL27595132 | 0.83 | ALDH1A1 (0.54) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL27719363 | 0.83 | ALDH1A1 (0.54) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL25960462 | 0.83 | ALDH1A1 (0.54) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL1749669 | 0.81 | PLA2G4B (0.65) | ALDH1A1PLA2G4B | |
| SCHEMBL27372528 | 0.81 | ALDH1A1 (0.53) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL28317367 | 0.81 | ALDH1A1 (0.53) | ALDH1A1NR4A2PLA2G4BRXRARXRB | |
| SCHEMBL27373602 | 0.81 | ALDH1A1 (0.53) | ALDH1A1NR4A2PLA2G4BRXRARXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101142180-B | Pyrrolidine derivatives as histamine h3 receptor antagonists | LILLY CO ELI | 2011-05-04 | — | — | CN | disclosed |
| CN-101142180-A | Pyrrolidine derivatives as histamine h3 receptor antagonists | LILLY CO ELI (US) | 2008-03-12 | — | — | CN | disclosed |